E2F7 and neoplasm: Inhibiting tumor growth, miR-29 targets explicitly cyclin D2 and E2F7 (112, 118, 126), and miR-26a, downregulated in this context, exerts tumor-suppressive effects by reducing EZH2 expression (113, 125).